Leona E. Ling, PhD

Head, Translational Science Autoantibody Pathway Area Stronghold
Johnson & Johnson Innovative Medicine

Poster(s):

• 052: Nipocalimab Pharmacokinetic/Pharmacodynamic & Exposure-Response Modeling in Pregnancies at Risk for Early-onset Severe (EOS) HDFN
  Sunday, September 8, 2024

  5:00 PM – 7:00 PM ET

• 166: Fetal & Neonatal Drug Exposure Following Nipocalimab Treatment in Pregnant Women at Risk of EOS-HDFN
  Monday, September 9, 2024

  5:00 PM – 7:00 PM ET